112 related articles for article (PubMed ID: 27993657)
1. Genome analysis of Chlamydia trachomatis for functional characterization of hypothetical proteins to discover novel drug targets.
Turab Naqvi AA; Rahman S; Rubi ; Zeya F; Kumar K; Choudhary H; Jamal MS; Kim J; Hassan MI
Int J Biol Macromol; 2017 Mar; 96():234-240. PubMed ID: 27993657
[TBL] [Abstract][Full Text] [Related]
2. Comparative genomic analysis of Chlamydia trachomatis oculotropic and genitotropic strains.
Carlson JH; Porcella SF; McClarty G; Caldwell HD
Infect Immun; 2005 Oct; 73(10):6407-18. PubMed ID: 16177312
[TBL] [Abstract][Full Text] [Related]
3. Comparative genomes of Chlamydia pneumoniae and C. trachomatis.
Kalman S; Mitchell W; Marathe R; Lammel C; Fan J; Hyman RW; Olinger L; Grimwood J; Davis RW; Stephens RS
Nat Genet; 1999 Apr; 21(4):385-9. PubMed ID: 10192388
[TBL] [Abstract][Full Text] [Related]
4. Shotgun proteomic analysis of Chlamydia trachomatis.
Skipp P; Robinson J; O'Connor CD; Clarke IN
Proteomics; 2005 Apr; 5(6):1558-73. PubMed ID: 15838905
[TBL] [Abstract][Full Text] [Related]
5. In vitro antichlamydial activity of garenoxacin against Chlamydia trachomatis.
Futakuchi N; Nakatani M; Takahata M; Mitsuyama J
J Infect Chemother; 2012 Aug; 18(4):428-35. PubMed ID: 22113367
[TBL] [Abstract][Full Text] [Related]
6. Sequence Analysis of Hypothetical Proteins from
Naqvi AA; Anjum F; Khan FI; Islam A; Ahmad F; Hassan MI
Genomics Inform; 2016 Sep; 14(3):125-135. PubMed ID: 27729842
[No Abstract] [Full Text] [Related]
7. TargeTron inactivation of plasmid-regulated Chlamydia trachomatis CT084 results in a nonlytic phenotype.
Karanovic U; Lei L; Martens CA; Barbian K; McClarty G; Caldwell HD; Yang C
Pathog Dis; 2023 Jan; 81():. PubMed ID: 37804183
[TBL] [Abstract][Full Text] [Related]
8. Functional annotation of hypothetical proteins from the Exiguobacterium antarcticum strain B7 reveals proteins involved in adaptation to extreme environments, including high arsenic resistance.
da Costa WLO; Araújo CLA; Dias LM; Pereira LCS; Alves JTC; Araújo FA; Folador EL; Henriques I; Silva A; Folador ARC
PLoS One; 2018; 13(6):e0198965. PubMed ID: 29940001
[TBL] [Abstract][Full Text] [Related]
9. [Localization of the hypothetical protein CT249 in the Chlamydia trachomatis inclusion membrane].
Jia TJ; Liu DW; Luo JH; Zhong GM
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):645-8. PubMed ID: 17944365
[TBL] [Abstract][Full Text] [Related]
10. In silico scrutiny of genes revealing phylogenetic congruence with clinical prevalence or tropism properties of Chlamydia trachomatis strains.
Ferreira R; Antelo M; Nunes A; Borges V; Damião V; Borrego MJ; Gomes JP
G3 (Bethesda); 2014 Nov; 5(1):9-19. PubMed ID: 25378473
[TBL] [Abstract][Full Text] [Related]
11. The Virulent Hypothetical Proteins: The Potential Drug Target Involved in Bacterial Pathogenesis.
Naveed M; Makhdoom SI; Abbas G; Safdari M; Farhadi A; Habtemariam S; Shabbir MA; Jabeen K; Asif MF; Tehreem S
Mini Rev Med Chem; 2022; 22(20):2608-2623. PubMed ID: 35422211
[TBL] [Abstract][Full Text] [Related]
12. Identification and evaluation of a combination of chlamydial antigens to support the diagnosis of severe and invasive Chlamydia trachomatis infections.
Forsbach-Birk V; Simnacher U; Pfrepper KI; Soutschek E; Kiselev AO; Lampe MF; Meyer T; Straube E; Essig A
Clin Microbiol Infect; 2010 Aug; 16(8):1237-44. PubMed ID: 19723133
[TBL] [Abstract][Full Text] [Related]
13. Localization and characterization of the hypothetical protein CT440 in Chlamydia trachomatis-infected cells.
Li Z; Huang Q; Su S; Zhou Z; Chen C; Zhong G; Wu Y
Sci China Life Sci; 2011 Nov; 54(11):1048-54. PubMed ID: 22173312
[TBL] [Abstract][Full Text] [Related]
14. Novel overlapping coding sequences in Chlamydia trachomatis.
Jensen KT; Petersen L; Falk S; Iversen P; Andersen P; Theisen M; Krogh A
FEMS Microbiol Lett; 2006 Dec; 265(1):106-17. PubMed ID: 17038047
[TBL] [Abstract][Full Text] [Related]
15. Structural and biochemical characterization of Chlamydia trachomatis hypothetical protein CT263 supports that menaquinone synthesis occurs through the futalosine pathway.
Barta ML; Thomas K; Yuan H; Lovell S; Battaile KP; Schramm VL; Hefty PS
J Biol Chem; 2014 Nov; 289(46):32214-32229. PubMed ID: 25253688
[TBL] [Abstract][Full Text] [Related]
16. Characterization of interactions between inclusion membrane proteins from Chlamydia trachomatis.
Gauliard E; Ouellette SP; Rueden KJ; Ladant D
Front Cell Infect Microbiol; 2015; 5():13. PubMed ID: 25717440
[TBL] [Abstract][Full Text] [Related]
17. Use of aminoglycoside 3' adenyltransferase as a selection marker for Chlamydia trachomatis intron-mutagenesis and in vivo intron stability.
Lowden NM; Yeruva L; Johnson CM; Bowlin AK; Fisher DJ
BMC Res Notes; 2015 Oct; 8():570. PubMed ID: 26471806
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the protein-coding gene content of Chlamydia trachomatis and Protochlamydia amoebophila using a Raspberry Pi computer.
Robson JF; Barker D
BMC Res Notes; 2015 Oct; 8():561. PubMed ID: 26462790
[TBL] [Abstract][Full Text] [Related]
19. Targeted Disruption of Chlamydia trachomatis Invasion by in Trans Expression of Dominant Negative Tarp Effectors.
Parrett CJ; Lenoci RV; Nguyen B; Russell L; Jewett TJ
Front Cell Infect Microbiol; 2016; 6():84. PubMed ID: 27602332
[TBL] [Abstract][Full Text] [Related]
20. Classification and Functional Analyses of Putative Conserved Proteins from Chlamydophila pneumoniae CWL029.
Khan S; Shahbaaz M; Bisetty K; Ahmad F; Hassan MI
Interdiscip Sci; 2017 Mar; 9(1):96-106. PubMed ID: 26649559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
